Stemcell United Ltd
ASX:SCU
Stemcell United Ltd
Research & Development
Stemcell United Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Stemcell United Ltd
ASX:SCU
|
Research & Development
-AU$279.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immutep Ltd
ASX:IMM
|
Research & Development
-AU$61.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-21%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Research & Development
-$34.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
CSL Ltd
ASX:CSL
|
Research & Development
-$1.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Research & Development
-AU$171.2m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Research & Development
-AU$65m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
-36%
|
|
Stemcell United Ltd
Glance View
Stemcell United Ltd. engages on using stem cell technology to grow and extract plant essence. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-06-13. The firm offers a range of products include Caulerpa lentillifera, Dendrobium officinale, Daemonorops draco Blume, and Cannabis sativa. The firm's geographical segments include Australia, Singapore, Greater China, and Malaysia.
See Also
What is Stemcell United Ltd's Research & Development?
Research & Development
-279.3k
AUD
Based on the financial report for Jun 30, 2022, Stemcell United Ltd's Research & Development amounts to -279.3k AUD.
What is Stemcell United Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-3%
Over the last year, the Research & Development growth was -3%.